Most Popular Articles : Menopause

Most Popular Articles

Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

Menopause. 28(9):973-997, September 2021.

Free
CME Test

Association of hormone preparations with bone mineral density, osteopenia, and osteoporosis in postmenopausal women: data from National Health and Nutrition Examination Survey 1999-2018

Wang, Yiran; Sun, Chao

Menopause. 30(6):591-598, June 2023.

Open

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

Gaspard, Ulysse; Taziaux, Mélanie; Jost, Maud; More

Menopause. 30(5):480-489, May 2023.

Open
SDC

Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update

Meziou, Nadia; Scholfield, Clare; Taylor, Caroline A.; More

Menopause. 30(6):659-671, June 2023.

Open
SDC

A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial

Barnard, Neal D.; Kahleova, Hana; Holtz, Danielle N.; More

Menopause. 30(1):80-87, January 2023.

Open
SDC

Safety and efficacy of compounded bioidentical hormone therapy (cBHT) in perimenopausal and postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

Liu, Yi; Yuan, Ying; Day, A.J.; More

Menopause. 29(4):465-482, April 2022.

Open
SDC

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

Portman, David J.; Kaunitz, Andrew M.; Kazempour, Kazem; More

Menopause. 21(10):1082-1090, October 2014.

Open
SDC

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

Pinkerton, JoAnn V.; Joffe, Hadine; Kazempour, Kazem; More

Menopause. 22(1):50-58, January 2015.

Open

A survey of medical cannabis use during perimenopause and postmenopause

Dahlgren, M. Kathryn; El-Abboud, Celine; Lambros, Ashley M.; More

Menopause. 29(9):1028-1036, September 2022.

Open
SDC

The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS): a randomized, controlled trial of a plant-based diet and whole soybeans for postmenopausal women

Barnard, Neal D.; Kahleova, Hana; Holtz, Danielle N.; More

Menopause. 28(10):1150-1156, October 2021.

Open
SDC

Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study

Roa-Díaz, Zayne Milena; Wehrli, Faina; Lambrinoudaki, Irene; More

Menopause. 30(6):599-606, June 2023.

Open
SDC

Association between weekend catch-up sleep and hyperuricemia with insufficient sleep in postmenopausal Korean women: a nationwide cross-sectional study

Son, Soo Min; Park, Eun-Ju; Kwon, Ryuk Jun; More

Menopause. 30(6):607-612, June 2023.

Open

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

Open
SDC

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

Simon, James A.; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 30(3):239-246, March 2023.

Open
SDC

The role of physical activity in the link between menopausal status and mental well-being

Bondarev, Dmitriy; Sipilä, Sarianna; Finni, Taija; More

Menopause. 27(4):398-409, April 2020.

Open
SDC

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. 26(10):1213-1227, October 2019.

Open

“It just makes me feel a little less alone”: a qualitative exploration of the podcast Menopause: Unmuted on women's perceptions of menopause

Edwards, Amy L.; Shaw, Philippa A.; Halton, Candida C.; More

Menopause. 28(12):1374-1384, December 2021.

Open
SDC

The 2022 hormone therapy position statement of The North American Menopause Society

Menopause. 29(7):767-794, July 2022.

CME Test
Buy

Sleep apnea in postmenopausal women is associated with joint pain severity and fatigability: a cross-sectional study

Odai, Tamami; Terauchi, Masakazu; Umeki, Hidenori; More

Menopause. 29(6):680-686, June 2022.

Open

Physical performance in relation to menopause status and physical activity

Bondarev, Dmitriy; Laakkonen, Eija K.; Finni, Taija; More

Menopause. 25(12):1432-1441, December 2018.

Open
SDC

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

Hirschberg, Angelica Lindén; Sánchez-Rovira, Pedro; Presa-Lorite, Jesús; More

Menopause. 27(5):526-534, May 2020.

Open
SDC

Systemic estradiol levels with low-dose vaginal estrogens

Santen, Richard J.; Mirkin, Sebastian; Bernick, Brian; More

Menopause. 27(3):361-370, March 2020.

Open

Risk factors for intrauterine device embedment in postmenopausal women: an analysis of 731 participants undergoing hysteroscopy

Jiang, Jilan; Bian, Shoufang; Li, Sen; More

Menopause. : May 09, 2023

Open
PAP

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Constantine, Ginger D.; Graham, Shelli; Lapane, Kate; More

Menopause. 26(7):800-807, July 2019.

Open
SDC

The 2023 nonhormone therapy position statement of The North American Menopause Society

Menopause. 30(6):573-590, June 2023.

CME Test
Buy

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Permissions

Free

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. 26(9):1071-1084, September 2019.

Open

Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers

DePree, Barbara; Houghton, Katherine; DiBenedetti, Dana B.; More

Menopause. 30(2):128-135, February 2023.

Open

The menopause transition: a critical stage for cardiovascular disease risk acceleration in women

El Khoudary, Samar R.

Menopause. 30(5):556-558, May 2023.

The MATE survey: men's perceptions and attitudes towards menopause and their role in partners’ menopausal transition

Parish, Sharon J.; Faubion, Stephanie S.; Weinberg, Marc; More

Menopause. 26(10):1110-1116, October 2019.

Open
SDC

Menopause and exercise

Grindler, Natalia M.; Santoro, Nanette F.

Menopause. 22(12):1351-1358, December 2015.

Predicting the age at natural menopause in middle-aged women

Hyvärinen, Matti; Karvanen, Juha; Aukee, Pauliina; More

Menopause. 28(7):792-799, July 2021.

Open
SDC

Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records

DePree, Barbara; Houghton, Katherine; Shiozawa, Aki; More

Menopause. 30(1):70-79, January 2023.

Open

Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause

Yu, Qi; Chae, Hee-Dong; Hsiao, Sheng-Mou; More

Menopause. 29(5):553-563, May 2022.

Open
SDC

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

Open

Tissue selective estrogen complex (TSEC): a review

Pickar, James H.; Boucher, Matthieu; Morgenstern, Diana

Menopause. 25(9):1033-1045, September 2018.

Open

Prevalence and risk factors for menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study

Wang, Xueyin; Wang, Linhong; Di, Jiangli; More

Menopause. 28(11):1271-1278, November 2021.

Open
SDC

Different regimens of menopausal hormone therapy for improving sleep quality: a systematic review and meta-analysis

Pan, Zhuo; Wen, Shu; Qiao, Xiaoyong; More

Menopause. 29(5):627-635, May 2022.

Open
SDC

Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey

Coslov, Nina; Richardson, Marcie K.; Woods, Nancy Fugate

Menopause. 28(9):1012-1025, September 2021.

Open
SDC

The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society

Menopause. 27(9):976-992, September 2020.

CME Test
Buy

Factors related to age at natural menopause in China: results from the China Kadoorie Biobank

Wang, Meng; Kartsonaki, Christiana; Guo, Yu; More

Menopause. 28(10):1130-1142, October 2021.

Open
SDC

Sexual activity and function assessment in middle-aged Chinese women using the female sexual function index

Zhang, Caiyun; Cui, Liping; Zhang, Lizhi; More

Menopause. 24(6):669-676, June 2017.

Open

The North American Menopause Society Recommendations for Clinical Care of Midlife Women

Shifren, Jan L.; Gass, Margery L.S.; for the NAMS Recommendations for Clinical Care of Midlife Women Working Group

Menopause. 21(10):1038-1062, October 2014.

PDF
Permissions

Association of plant-based diet and early onset of natural menopause

Grisotto, Giorgia; Langton, Christine R.; Li, Yanping; More

Menopause. 29(7):861-867, July 2022.

Open
SDC

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

Open
SDC

Menopause preparedness: perspectives for patient, provider, and policymaker consideration

Aninye, Irene O.; Laitner, Melissa H.; Chinnappan, Shivani

Menopause. 28(10):1186-1191, October 2021.

Open

Update on estrogen therapy and prevention of bone loss

Nachtigall, Margaret; Nachtigall, Lila

Menopause. 30(6):567-568, June 2023.

PDF
Permissions

Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden

Nappi, Rossella E.; Kroll, Robin; Siddiqui, Emad; More

Menopause. 28(8):875-882, August 2021.

Open
SDC

Treating where it hurts—a randomized comparative trial of vestibule estradiol for postmenopausal dyspareunia

Goetsch, Martha F.; Garg, Bharti; Lillemon, Jen; More

Menopause. 30(5):467-475, May 2023.

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

Open

Diagnosis, causes, and treatment of dyspareunia in postmenopausal women

Streicher, Lauren F.

Menopause. 30(6):635-649, June 2023.

Effect of 2 years of endurance and high-impact training on preventing osteoporosis in postmenopausal women: randomized clinical trial

García-Gomáriz, Carmen; Blasco, José M.; Macián-Romero, Cecili; More

Menopause. 25(3):301-306, March 2018.

Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study

Yuk, Jin-Sung; Kim, Jung Min

Menopause. 30(5):497-505, May 2023.

Physical activity and exercise for hot flashes: trigger or treatment?

Witkowski, Sarah; Evard, Rose; Rickson, Jacquelyn J.; More

Menopause. 30(2):218-224, February 2023.

The 2017 hormone therapy position statement of The North American Menopause Society

The North American Menopause Society

Menopause. 24(7):728-753, July 2017.

CME Test
Buy

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study

Coelingh Bennink, Herjan J.T.; Verhoeven, Carole; Zimmerman, Yvette; More

Menopause. 24(6):677-685, June 2017.

Open

Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies

Stanczyk, Frank Z.; Niu, Chunying; Azen, Colleen; More

Menopause. 26(9):966-971, September 2019.

Open
SDC

Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications

Glaser, Rebecca L.; York, Anne E.; Dimitrakakis, Constantine

Menopause. 24(7):859-864, July 2017.

Open

Natural history and malignant potential of simple ovarian cysts in postmenopausal women: a systematic review and meta-analysis

Liu, Ya-Na; Tan, Xin; Xiong, Wei; More

Menopause. 30(5):559-565, May 2023.

Endometrial safety of low-dose vaginal estrogens

Stanczyk, Frank Z.; Mandelbaum, Rachel S.; Matharu, Harpreet; More

Menopause. 30(6):650-658, June 2023.

Efficacy of black rice extract on obesity in obese postmenopausal women: a 12-week randomized, double-blind, placebo-controlled preliminary clinical trial

Jung, Ah Jin; Sharma, Anshul; Lee, Sung-Hyen; More

Menopause. 28(12):1391-1399, December 2021.

Open
SDC

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial

Black, Denise R.; Minkin, Mary Jane; Graham, Shelli; More

Menopause. 28(1):32-39, January 2021.

Open

Menopause hormone therapy and urinary symptoms: a systematic review

Christmas, Monica M.; Iyer, Shilpa; Daisy, Cassandra; More

Menopause. 30(6):672-685, June 2023.

Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis

Harder, Helena; Starkings, Rachel M.L.; Fallowfield, Lesley J.; More

Menopause. 26(10):1100-1009, October 2019.

Open
SDC

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial

Trower, Mike; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 27(5):498-505, May 2020.

Open

Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall

Ripperda, Christopher M.; Maldonado, Pedro Antonio; Acevedo, Jesus F.; More

Menopause. 24(7):838-849, July 2017.

Open
SDC

The genitourinary syndrome of menopause

Phillips, Nancy A.; Bachmann, Gloria A.

Menopause. 28(5):579-588, May 2021.

Hormone therapy and midlife sexuality—is estrogen a hormone of desire?

Shifren, Jan L.

Menopause. 30(6):571-572, June 2023.

PDF
Permissions

Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis

Sugisawa, Akiyuki; Toyoda, Zensei; Tanabe, Yasuka; More

Menopause. 30(2):193-200, February 2023.

Open

Lipid profile differences during menopause: a review with meta-analysis

Ambikairajah, Ananthan; Walsh, Erin; Cherbuin, Nicolas

Menopause. 26(11):1327-1333, November 2019.

The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance

Grandi, Giovanni; Fiocchi, Federica; Cortesi, Laura; More

Menopause. 29(1):63-72, January 2022.

Open

The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context

Chlebowski, Rowan T.; Aragaki, Aaron K.

Menopause. 30(4):454-461, April 2023.

Cognition and the menopause transition

Maki, Pauline M.; Henderson, Victor W.

Menopause. 23(7):803-805, July 2016.

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society

Menopause. 22(11):1155-1174, November 2015.

CME Test
Buy

Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study

Arraras, Juan Ignacio; Illarramendi, Jose Juan; Manterola, Ana; More

Menopause. 30(6):613-620, June 2023.

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

Kroll, Robin; Archer, David F.; Lin, Yuhua; More

Menopause. 25(2):133-138, February 2018.

Open

SLCO1B1 genetic variation and hormone therapy in menopausal women

Moyer, Ann M.; de Andrade, Mariza; Faubion, Stephanie S.; More

Menopause. 25(8):877-882, August 2018.

Open

Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients

Pederson, Holly J.; Batur, Pelin

Menopause. 30(3):341-347, March 2023.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Open

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

Simon, James A.; Portman, David J.; Kaunitz, Andrew M.; More

Menopause. 20(10):1027-1035, October 2013.

Free

Gabapentin for the treatment of hot flushes in menopause: a meta-analysis

Yoon, Sang-Hee; Lee, Ji Young; Lee, Chulmin; More

Menopause. 27(4):485-493, April 2020.

Dairy intake is not associated with improvements in bone mineral density or risk of fractures across the menopause transition: data from the Study of Women's Health Across the Nation

Wallace, Taylor C.; Jun, Shinyoung; Zou, Peishan; More

Menopause. 27(8):879-886, August 2020.

Open
SDC

Early menopause and cardiovascular risk: directionality matters

Nudy, Matthew; Cooper, Jennifer L.; Schnatz, Peter F.

Menopause. 30(6):569-570, June 2023.

PDF
Permissions

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety

Gaspard, Ulysse; Taziaux, Mélanie; Mawet, Marie; More

Menopause. 27(8):848-857, August 2020.

Open
SDC

A 16-week multicomponent exercise training program improves menopause-related symptoms in middle-aged women. The FLAMENCO project randomized control trial

Baena-García, Laura; Flor-Alemany, Marta; Marín-Jiménez, Nuria; More

Menopause. 29(5):537-544, May 2022.

Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments

Gambacciani, Marco

Menopause. 30(5):463-464, May 2023.

PDF
Permissions

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging

Harlow, Siobán D.; Gass, Margery; Hall, Janet E.; More

Menopause. 19(4):387-395, April 2012.

Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review

Dolitsky, Shelley N.; Cordeiro Mitchell, Christina N.; Stadler, Sarah Sheehan; More

Menopause. 28(2):217-224, February 2021.

Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis

Li, Zhen-Yu; Dong, Ying-Li; Cao, Xiao-Zhong; More

Menopause. 29(9):1093-1100, September 2022.

Open

Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study

Miller, Virginia M.; Hodis, Howard N.; Lahr, Brian D.; More

Menopause. 26(1):24-31, January 2019.

Open
SDC

Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery

Nowakowski, Łukasz; Gałczyński, Krzysztof; Dybowski, Michał; More

Menopause. 30(6):629-634, June 2023.

Effect of laser acupuncture on pain and density of bone in osteoporotic postmenopausal women: a randomized controlled trial

Hassan, Elham S.; Maged, Ahmed Mohamed; Kotb, Amal; More

Menopause. 30(5):545-550, May 2023.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Permissions

Free

Sarcopenia and menopause

Liu, James H.

Menopause. 30(2):119-120, February 2023.

PDF
Permissions

One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus

Simon, James A.; Lin, Vivian H.; Radovich, Cathy; More

Menopause. 20(4):418-427, April 2013.

Free

Genitourinary syndrome of menopause: a systematic review on prevalence and treatment

Mili, Nikoletta; Paschou, Stavroula A.; Armeni, Anastasia; More

Menopause. 28(6):706-716, June 2021.

The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study

Wu, Chia-Chen; Chung, Chi-Hsiang; Tzeng, Nian-Sheng; More

Menopause. 30(5):521-528, May 2023.

Interactions between genetic variants and environmental risk factors are associated with the severity of pelvic organ prolapse

Li, Lei; Zhao, Guangyi; Wu, Jie; More

Most Popular Articles : Menopause

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief: